Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)

Tina Shih, Chien
  • ClinicoEconomics and Outcomes Research, July 2012, Taylor & Francis
  • DOI: 10.2147/ceor.s27770

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/ceor.s27770

The following have contributed to this page: chun-ru chien